Botanical species · safety record

Saraca indica

The EFSA Compendium of Botanicals holds 8 constituent measurements for Saraca indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Saraca indica L.

8Constituent measurements

0Safety records

4Cited sources

18Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 18 licensed products naming Saraca indica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aged bark
Bark
Bark extract
Branch bark
Stem bark
Tincture of the bark
Trunk bark

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lectins	Flower	Solvent extraction	—	Electrophoretical tests	Resolve DOI
Lectins	Seed	Solvent extraction	—	Electrophoretical tests	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Cardiac glycosides	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Gallic acid	Bark	—	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Das, Joysree., Abul Manchur, Mohammad., Bin Emran, Talha., Uddin, Md. Forhad. Antioxidant, cytotoxic and phytochemical properties of the ethanol extract of Saraca indica leaf. Journal of pharmacy research (mandsaur, india), 2012, p. 5530-5533.
Ashokrao, N.S., Siddheshwar A.S., Jayaram C.M., Chandra P.S. An overview of Saraca indica: Chemistry and pharmacological profile. Indian drugs, 2006, vol. 43, no. 4, p. 277-281.
Chatterjee, Bishnu P., Majumder, Mainak. On the differential sialic acid specificity of lectins from different parts of Saraca indica. . Advances in experimental medicine and biology, 2011, vol. 705, p. 213-28. DOI
Ketkar, Pushkar M., Nayak, Shraddha U., Pai, Sandeep R., Joshi, Rajesh K. Determining Seasonal Changes in Three Major Phenolic Compounds from Bark of Saraca asoca in Comparison with Local Market Sample Using RP-HPLC Analysis. National academy science letters (india), 2015, p. 403-407.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature